Vivos (RDGL) Preferred Stock Liabilities (2015 - 2017)
Vivos (RDGL) reported Preferred Stock Liabilities of $12.0 million for Q2 2017, down 31.73% on a YoY basis from $17.6 million in Q2 2016, and up 2.24% sequentially from $11.7 million in Q1 2017.
Vivos (RDGL) Preferred Stock Liabilities (2015 - 2017) Analysis & Trends
Vivos (RDGL) has 3 years of Preferred Stock Liabilities data on file, last reported at $12.0 million in Q2 2017.
- For the quarter ending Q2 2017, Preferred Stock Liabilities fell 31.73% year-over-year to $12.0 million; the trailing twelve-month figure through Jun 2017 stood at $12.0 million (down 31.73% YoY), and the FY2016 full-year result was $14.1 million, up 206.36% from the prior year.
- Preferred Stock Liabilities advanced to $12.0 million in Q2 2017, from $11.7 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $17.9 million in Q3 2016 to a low of $4.6 million in Q4 2015.
- A 3-year average of $12.0 million and a median of $12.0 million in 2017 frame the typical range for Preferred Stock Liabilities.
- Across the five-year window, Preferred Stock Liabilities jumped 206.36% in 2016 and slumped 31.73% in 2017, its largest moves.
- Tracing RDGL's Preferred Stock Liabilities over 3 years: stood at $4.6 million in 2015, then jumped by 206.36% to $14.1 million in 2016, then declined by 15.11% to $12.0 million in 2017.
- Business Quant data shows RDGL's Preferred Stock Liabilities at $12.0 million in Q2 2017, $11.7 million in Q1 2017, and $14.1 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 12.01 Mn |
| Mar 31, 2017 | 11.74 Mn |
| Dec 31, 2016 | 14.14 Mn |
| Sep 30, 2016 | 17.85 Mn |
| Jun 30, 2016 | 17.59 Mn |
| Mar 31, 2016 | 6.16 Mn |
| Dec 31, 2015 | 4.62 Mn |